We are live on
!
Find out more
CC
ClearArc Capital Portfolio holdings
AUM
$257M
1-Year Est. Return
33.81%
This Fund
S&P 500
This Quarter
Est. Return
+7.11%
1 Year Est. Return
+33.81%
3 Year Est. Return
+63.41%
5 Year Est. Return
+95.17%
10 Year Est. Return
–
AUM
$736M
AUM Growth
+$70.5M
(+11%)
Cap. Flow
+$28.6M
Cap. Flow
% of AUM
3.88%
Top 10 Holdings %
Top 10 Hldgs %
18.76%
Holding
469
New
7
Increased
98
Reduced
355
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$3.81M |
| 2 |
Citigroup
C
|
+$3.35M |
| 3 |
McDonald's
MCD
|
+$3.18M |
| 4 |
Stanley Black & Decker
SWK
|
+$3.09M |
| 5 |
Estee Lauder
EL
|
+$3.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$2.41M |
| 2 |
Dominion Energy
D
|
+$1.7M |
| 3 |
Visa
V
|
+$1.33M |
| 4 |
Wells Fargo
WFC
|
+$793K |
| 5 |
Stryker
SYK
|
+$616K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.31% |
| 2 | Technology | 15.17% |
| 3 | Healthcare | 12.16% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Discretionary | 8.6% |
Similar funds
BO
GCA
QCM
AEPI
AC
LA
JFM
SHA
ClearArc Capital's Q4 2017 Portfolio in Review
As of Q4 2017, ClearArc Capital held 469 positions worth $736M, up 11% from $666M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
ClearArc Capital deployed $28.6M of net new capital in Q4 2017, opening 7 new positions and adding to 98 existing holdings. Its largest new stake was Pultegroup: 6,865 shares worth $228K.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $2.41M trimmed.
- ClearArc Capital's largest Q4 2017 buy was Pultegroup: 6,865 shares worth $228K.
- ClearArc Capital added most to MGM Growth Properties LLC Class A common shares representing limited liability company interests in Q4 2017, an estimated $3.81M increase.
- ClearArc Capital's biggest Q4 2017 reduction was Gilead Sciences, cutting an estimated $2.41M.
- ClearArc Capital fully exited CR Bard Inc. in Q4 2017, selling an estimated $599K.
- ClearArc Capital's ten largest holdings make up 19% of its $736M portfolio in Q4 2017.
- ClearArc Capital opened 7 new positions and closed 6 in Q4 2017.
- ClearArc Capital's portfolio value rose 11% quarter-over-quarter to $736M.
Based on ClearArc Capital's 13F filing for Q4 2017, filed 14 Feb 2018.